Kellie L. Bodeker

1.7k total citations
22 papers, 577 citations indexed

About

Kellie L. Bodeker is a scholar working on Surgery, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Kellie L. Bodeker has authored 22 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Oncology and 4 papers in Nutrition and Dietetics. Recurrent topics in Kellie L. Bodeker's work include Neuroendocrine Tumor Research Advances (3 papers), Vitamin D Research Studies (3 papers) and Vitamin C and Antioxidants Research (3 papers). Kellie L. Bodeker is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Vitamin D Research Studies (3 papers) and Vitamin C and Antioxidants Research (3 papers). Kellie L. Bodeker collaborates with scholars based in United States and Germany. Kellie L. Bodeker's co-authors include John M. Buatti, Joseph J. Cullen, Juan Du, Brett A. Wagner, Daniel Berg, Garry R. Buettner, Jessemae L. Welsh, Jeanne Drisko, Þorvarður R. Hálfdánarson and Mark Levine and has published in prestigious journals such as Cancer Research, Free Radical Biology and Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Kellie L. Bodeker

21 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kellie L. Bodeker United States 11 230 135 126 96 82 22 577
Pamela Zehr United States 9 175 0.8× 94 0.7× 65 0.5× 28 0.3× 76 0.9× 18 420
Sarit Assouline Canada 12 254 1.1× 280 2.1× 349 2.8× 26 0.3× 195 2.4× 37 866
Feng Bi China 14 39 0.2× 33 0.2× 256 2.0× 129 1.3× 148 1.8× 31 724
Sila Appak‐Baskoy Canada 14 39 0.2× 104 0.8× 154 1.2× 25 0.3× 140 1.7× 19 563
K.C. Balaji United States 12 57 0.2× 39 0.3× 166 1.3× 51 0.5× 115 1.4× 51 608
Simin Hemati Iran 13 41 0.2× 38 0.3× 113 0.9× 78 0.8× 100 1.2× 52 429
Masashi Kitagawa Japan 15 48 0.2× 41 0.3× 152 1.2× 16 0.2× 22 0.3× 35 665
Caroline Le Lan France 13 470 2.0× 43 0.3× 100 0.8× 9 0.1× 18 0.2× 20 1.0k

Countries citing papers authored by Kellie L. Bodeker

Since Specialization
Citations

This map shows the geographic impact of Kellie L. Bodeker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie L. Bodeker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie L. Bodeker more than expected).

Fields of papers citing papers by Kellie L. Bodeker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kellie L. Bodeker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie L. Bodeker. The network helps show where Kellie L. Bodeker may publish in the future.

Co-authorship network of co-authors of Kellie L. Bodeker

This figure shows the co-authorship network connecting the top 25 collaborators of Kellie L. Bodeker. A scholar is included among the top collaborators of Kellie L. Bodeker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kellie L. Bodeker. Kellie L. Bodeker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bodeker, Kellie L., Bruce A. Smith, Daniel Berg, et al.. (2024). A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biology. 77. 103375–103375. 14 indexed citations
2.
Petronek, Michael S., Kellie L. Bodeker, Karra A. Jones, et al.. (2024). Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial. Journal of Neuro-Oncology. 166(3). 493–501. 4 indexed citations
3.
Bushnell, David, Kellie L. Bodeker, Thomas M. O’Dorisio, et al.. (2021). Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 62(9). 1274–1277. 14 indexed citations
4.
Daniel, Casey L., Carryn M. Anderson, Samuel N. Rodman, et al.. (2021). Ketogenic Diet with Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma: Preclinical and Phase 1 Trial Results. Radiation Research. 196(2). 213–224. 26 indexed citations
5.
Bushnell, David & Kellie L. Bodeker. (2020). Overview and Current Status of Peptide Receptor Radionuclide Therapy. Surgical Oncology Clinics of North America. 29(2). 317–326. 13 indexed citations
6.
Alexander, Matthew S., Justin G. Wilkes, Garry R. Buettner, et al.. (2018). Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Cancer Research. 78(24). 6838–6851. 89 indexed citations
7.
Smith, Mark C., et al.. (2018). Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas. Practical Radiation Oncology. 9(1). 16–23. 13 indexed citations
8.
Daele, Douglas J. Van, Kellie L. Bodeker, & Douglas K. Trask. (2016). Celecoxib Versus Placebo in Tonsillectomy. Annals of Otology Rhinology & Laryngology. 125(10). 785–800. 9 indexed citations
9.
Kurland, Brenda F., Sameer Aggarwal, Thomas E. Yankeelov, et al.. (2016). Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) Survey. Tomography. 2(4). 276–282. 1 indexed citations
10.
Anderson, Carryn M., Kellie L. Bodeker, Wenqing Sun, et al.. (2016). A Phase 1 Trial of Ketogenic Diet With Concurrent Chemoradiation (CRT) in Head and Neck Squamous Cell Carcinoma (HNSCC). International Journal of Radiation Oncology*Biology*Physics. 94(4). 898–898. 3 indexed citations
11.
Welsh, Jessemae L., Brett A. Wagner, Thomas J. van ‘t Erve, et al.. (2013). Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemotherapy and Pharmacology. 71(3). 765–775. 226 indexed citations
12.
Jacobson, Geraldine M., Sudershan K. Bhatia, Bruce A. Smith, et al.. (2012). Randomized Trial of Pentoxifylline and Vitamin E vs Standard Follow-up After Breast Irradiation to Prevent Breast Fibrosis, Evaluated by Tissue Compliance Meter. International Journal of Radiation Oncology*Biology*Physics. 85(3). 604–608. 80 indexed citations
13.
14.
Brandt, Debra, et al.. (2011). A CTSA‐Sponsored Program for Clinical Research Coordination: Networking, Education, and Mentoring. Clinical and Translational Science. 4(1). 42–47. 7 indexed citations
15.
Gupta, Amit, Werner W. Wilke, Erik N. Taylor, et al.. (2009). Signaling Pathways in Adenoid Cystic Cancers: Implications for Treatment. International Journal of Radiation Oncology*Biology*Physics. 75(3). S546–S546. 1 indexed citations
16.
Gupta, Anjali, Werner W. Wilke, Kellie L. Bodeker, et al.. (2009). Signaling pathways in adenoid cystic cancers: Implications for treatment. Cancer Biology & Therapy. 8(20). 1947–1951. 14 indexed citations
17.
Froster‐Iskenius, U., Kellie L. Bodeker, R. D. Matthes, et al.. (1986). Folic acid treatment in males and females with fragile‐(X)‐syndrome. American Journal of Medical Genetics. 23(1-2). 273–289. 27 indexed citations
18.
Bodeker, Kellie L., et al.. (1981). [Electrophysiologic effects of dopamine on the cardiac conduction system (author's transl)].. PubMed. 70(9). 643–51.
19.
Bodeker, Kellie L., et al.. (1980). [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].. PubMed. 69(11). 790–6. 1 indexed citations
20.
Hager, W, et al.. (1979). [Electrophysiologic effects of dobutamine on cardiac conduction system (author's transl)].. PubMed. 68(3). 137–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Zehr Breakdown of academic impact, for papers by Sarit Assouline Breakdown of academic impact, for papers by Feng Bi Breakdown of academic impact, for papers by Sila Appak‐Baskoy Breakdown of academic impact, for papers by K.C. Balaji Breakdown of academic impact, for papers by Simin Hemati Breakdown of academic impact, for papers by Masashi Kitagawa Breakdown of academic impact, for papers by Caroline Le Lan
Rankless by CCL
2026